Effectiveness of pramipexole, a dopamine agonist, on rapid eye movement sleep behavior disorder.
This study was undertaken to evaluate the effectiveness and mechanism of action of pramipexole, a dopamine agonist, on RBD symptoms. Fifteen patients (57-75 years old) with RBD with a PLMS index of more than 15 events/h shown by nocturnal polysomnography were enrolled. Sleep variables, the score of severity for RBD symptoms, REM density, and PLM index were compared before and after one month or more of consecutive pramipexole treatment. Correlation analysis was conducted between the rate of change in RBD symptoms and the rate of reduction of REM density. Fourteen...
Published By: MedWorm/EatingDisorder - Wednesday, 22 February
- Older News
Vote! Dopamine: the two-faced molecule behind addiction and Parkinson's disease - video MedWorm/EatingDisorder (Yesterday) - The hormone dopamine is responsible for the cravings of addiction, but when levels are abnormally...